Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life StudyAndrea Picchianti Diamanti, Annamaria Iagnocco, Bruno Frediani et al.|Rheumatology and Therapy|2024Cited by 11
Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS studyAndrea Picchianti Diamanti, Annamaria Iagnocco, Valentino Paci et al.|Arthritis Research & Therapy|2025Cited by 1
AB0526 CLINICAL AND ULTRASONOGRAPHIC REMISSION IN BIO-NAÏVE AND BIO-FAILURE RHEUMATOID ARTHRITIS PATIENTS AT 24-WEEK OF UPADACITINIB TREATMENT: THE UPARAREMUS REAL-LIFE STUDYAnnamaria Iagnocco, Maria Sofia Cattaruzza, Simonetta Salemi et al.|Annals of the Rheumatic Diseases|2024Cited by 0
Clinical and Ultrasound Remission at 48 Weeks of Upadacitinib in Rheumatoid Arthritis: Real-World Results from the Italian Multicenter UPARAREMUS StudyAndrea Picchianti Diamanti, Annamaria Iagnocco, Valentino Paci et al.|Research Square|2025Cited by 0